A Study of Oncobax®-AK in Patients With Advanced Solid Tumors

Clinical trial NCT05865730 · UNKNOWN

Trial details

NCT number: NCT05865730
Sponsor: EverImmune
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell Carcinoma, Non-Small-Cell Lung

Start date: 2022-10-01
Primary completion: 2025-06-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.